ASPI vs BDX · rev $23.8M vs P/E 34, rev $21.84B
ASP Isotopes Inc. Common Stock (ASPI) versus Becton Dickinson and Company (BDX) — a side-by-side from cached financials, not a winner call.
ASP Isotopes Inc. Common Stock (ASPI) is a chemicals company listed on US.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Latest reported ASPI revenue for 2025-12-31 was $23.8M. Net income was -$159.8M. Revenue was up 475.5% from 2024-12-31 to 2025-12-31. ASPI currently screens at market cap $620.7M.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
ASPI currently screens at market cap $620.7M. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Not investment advice. Open the ASPI and BDX stock pages for the full models.
Not investment advice.